Sommaire - 1 - Innovation Summit Roles for Stakeholders in the Healthcare System July 2010
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Sommaire- 1 -
Innovation SummitRoles for Stakeholders in the Healthcare System
July 2010
- 2 -
July 2010
Australia – Transparency in PBS Reimbursed Medicines
HTA introduced the late 1990’s
AUSFTA - Free Trade Agreement - 1st January 2005Provided the opportunity to challenge PBAC decisions
PBS reform Nov 2006Pricing disclosure - respects commercial in confidence , takes into account rebates, discounts and non
momentary benefits at a pharmacy level
Weighted average price
Delinking of patented to off-patented products
PBS Summary Documents – gives transparency to PBAC’s decision making (available on the internet):
“The availability of Public Summary Documents (PSDs) is the result of initiatives coming out of
the Australian-United States Free Trade Agreement (AUSFTA) based on transparency
principles supporting the provision of information regarding the basis for the subsidy of
pharmaceuticals to the Australian community, through the Pharmaceutical Benefits Scheme “
The structure of the PSD is the result of collaboration between the Australian Government and the
Pharmaceutical Industry, and is aimed at providing consistent information across PBAC
recommendations.
- 3 -
July 2010
Australia – Transparency in PBS Reimbursed Medicines
Access to Medicines Working GroupBetween Health Department and Pharmaceutical Industry - forum to discuss price reductions, accelerated
listing of medicines (parallel tracking), impact of generic price reductions on innovative medicines
Horizon scanning – expected submissions and latest medical technologies
PBAC SubmissionMedicines Australia representatives on 2 subcommittees – Economic Subcommittee and Drug Utilisation
subcommittee as full members
10 minute hearings before the committee
Pharmaceutical Benefits Pricing Authority Provides advise to the Minister of Health
Medicines Australia CEO member of the committee
This group was formed by the Department of Health and Ageing and Medicines Australia to
help them work together more effectively and to consider issues regarding timely and
appropriate access to new medicines for the PBS. The Group meets three to four times a
year.
Related Documents
